HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Li-Yu Wang Selected Research
Li-Yu Wang Research Topics
Disease
22
Hepatocellular Carcinoma (Hepatoma)
01/2019 - 05/2002
19
Infections
01/2021 - 01/2004
12
Neoplasms (Cancer)
03/2022 - 05/2002
12
Chronic Hepatitis B
01/2022 - 05/2008
12
Fibrosis (Cirrhosis)
01/2019 - 08/2007
9
Hepatitis B
10/2019 - 05/2007
7
Liver Diseases (Liver Disease)
08/2014 - 01/2007
4
Liver Cirrhosis (Hepatic Cirrhosis)
01/2016 - 05/2011
3
Liver Neoplasms (Liver Cancer)
01/2019 - 10/2004
3
Hepatitis C
08/2012 - 02/2005
2
Body Weight (Weight, Body)
07/2022 - 01/2009
2
Viral Pneumonia
06/2021 - 02/2021
2
Human Influenza (Influenza)
06/2021 - 02/2021
2
Atherosclerosis
01/2019 - 08/2009
2
Carotid Artery Diseases
01/2019 - 08/2009
2
Lung Neoplasms (Lung Cancer)
04/2018 - 01/2016
2
Neoplasm Metastasis (Metastasis)
01/2017 - 01/2017
2
Fatty Liver
08/2014 - 01/2009
2
Non-alcoholic Fatty Liver Disease
08/2009 - 01/2009
2
Insulin Resistance
08/2009 - 01/2009
2
Obesity
01/2009 - 07/2008
2
Viremia
01/2007 - 01/2007
1
Esophageal Squamous Cell Carcinoma
03/2022
1
Inflammation (Inflammations)
06/2021
1
Pneumonia (Pneumonitis)
06/2021
1
Virus Diseases (Viral Diseases)
06/2021
1
Weight Gain
06/2021
1
Overweight
11/2018
1
Hypoxia (Hypoxemia)
01/2018
1
Hemorrhage
09/2017
1
Myocardial Infarction
09/2017
1
Stroke (Strokes)
09/2017
1
Atrial Fibrillation
09/2017
1
Thrombosis (Thrombus)
09/2017
1
Colorectal Neoplasms (Colorectal Cancer)
01/2017
1
Chronic Kidney Failure (Chronic Renal Failure)
01/2017
1
Disease Progression
01/2016
1
Overactive Urinary Bladder (Overactive Bladder)
08/2014
Drug/Important Bio-Agent (IBA)
21
Hepatitis B Surface Antigens (HBsAg)
FDA Link
01/2022 - 05/2002
12
DNA (Deoxyribonucleic Acid)
IBA
01/2019 - 04/2007
12
Hepatitis B e Antigens
IBA
01/2019 - 07/2002
8
Alanine Transaminase (SGPT)
IBA
01/2021 - 01/2009
7
RNA (Ribonucleic Acid)
IBA
01/2017 - 02/2005
5
Aflatoxin B1 (Aflatoxin B)
IBA
01/2018 - 05/2007
4
Antiviral Agents (Antivirals)
IBA
06/2021 - 05/2012
4
Surface Antigens (Surface Antigen)
IBA
01/2019 - 05/2007
4
Biomarkers (Surrogate Marker)
IBA
11/2018 - 04/2007
4
Aflatoxins
IBA
03/2009 - 05/2007
3
Proteins (Proteins, Gene)
FDA Link
03/2022 - 01/2017
2
Phospholipases (Phospholipase)
IBA
06/2021 - 02/2021
2
Albumins
IBA
01/2017 - 07/2007
2
ORALIT (ORS)
IBA
01/2016 - 03/2009
2
HLA-DPB1 antigen (HLA DPB1)
IBA
05/2015 - 10/2013
2
Antibodies
IBA
10/2014 - 07/2002
2
Transaminases (Aminotransferases)
IBA
01/2014 - 08/2009
2
HLA Antigens (Human Leukocyte Antigens)
IBA
10/2013 - 02/2005
2
Trihalomethanes
IBA
01/2010 - 10/2007
2
Drinking Water
IBA
01/2010 - 10/2007
2
Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)
IBA
07/2007 - 05/2002
1
Acetaminophen (Paracetamol)
FDA Link
Generic
07/2022
1
Caspase 9
IBA
03/2022
1
rutecarpine
IBA
03/2022
1
Proliferating Cell Nuclear Antigen (PCNA)
IBA
03/2022
1
Caspase 3 (Caspase-3)
IBA
03/2022
1
daidzein
IBA
06/2021
1
arctiin
IBA
06/2021
1
liquiritin
IBA
06/2021
1
Glycyrrhizic Acid (Glycyrrhizin)
IBA
06/2021
1
HLA-DPA1 antigen (HLA DPA1)
IBA
10/2019
1
Lipids
IBA
01/2019
1
Sugars
IBA
01/2019
1
Bone Morphogenetic Proteins (Bone Morphogenetic Protein)
IBA
01/2019
1
low density lipoprotein inhibitor
IBA
11/2018
1
Tea
IBA
11/2018
1
oxidized low density lipoprotein
IBA
11/2018
1
Leptin
IBA
11/2018
1
LDL Cholesterol
IBA
11/2018
1
linderalactone
IBA
04/2018
1
Nucleoside-Diphosphate Kinase
IBA
04/2018
1
Matrix Metalloproteinases (MMPs)
IBA
04/2018
1
Catenins
IBA
04/2018
1
Facilitative Glucose Transport Proteins (Glucose Transporter)
IBA
01/2018
1
Oxygen (Dioxygen)
IBA
01/2018
1
Chondroitin Sulfates (Chondroitin Sulfate)
IBA
01/2018
1
omega-Chloroacetophenone (Mace)
IBA
09/2017
1
Anticoagulants
IBA
09/2017
1
Carbon
IBA
01/2017
1
Peroxisome Proliferator-Activated Receptors (PPAR)
IBA
01/2016
1
Quercetin
IBA
01/2016
Therapy/Procedure
2
Therapeutics
07/2017 - 07/2014
2
Renal Dialysis (Hemodialysis)
01/2007 - 01/2007
2
Peritoneal Dialysis
01/2007 - 01/2007
2
Continuous Ambulatory Peritoneal Dialysis (CAPD)
01/2007 - 01/2007
1
Oral Administration
06/2021
1
Meditation
01/2018
1
Stents
09/2017
1
Percutaneous Coronary Intervention
09/2017
1
Operative Surgical Procedures
01/2017
1
Kidney Transplantation
01/2017
1
Operative Time
01/2017